Search for: "In Re Upset Price Tax Sale" Results 21 - 32 of 32
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jan 2012, 3:53 pm by Mandelman
Along with creating so-called moral hazard, the step may also tighten lending by forcing banks to offer “price protection” to borrowers, he said. [read post]
3 May 2016, 2:41 pm by Rebecca Tushnet
What I hear is that it’s perfect or that it’s a second-best and any tinkering will upset parties. [read post]
21 Dec 2011, 9:11 am by Max Kennerly, Esq.
That the “special committee” formed to “independently” review the sale (because Grupo Mexico was quite obviously a controlling shareholder) used a preposterously foolish “relative valuation” method that inexplicably de-valued Southern Peru’s own publicly-traded stock to justify the sale? [read post]
30 Aug 2010, 8:34 am by Mandelman
I talk to a lot of homeowners from all over the country every single day, and it’s been like that for almost two years now. [read post]
7 Jun 2019, 3:00 am by Jim Sedor
And McConnell’s re-election campaigns have received more than $1 million in contributions from Chao’s extended family. [read post]
25 Nov 2017, 2:39 am by familoo
And his about-to-be-released self styled “debut” book is by all accounts doing roaring pre-order sales. [read post]
9 Dec 2010, 9:03 pm by Adam Thierer
He notes, for example, that “Over the centuries, societies have declared many technologies to be dangerous, economically upsetting, immoral, unwise, or simply too unknown for our good. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) – Lundbeck wins… [read post]